Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Host‐parasite dynamics in Chagas disease from systemic to hyper‐local scales
Damián Pérez‐Mazliah, Alexander I. Ward, Michael D. Lewis
Parasite Immunology (2020) Vol. 43, Iss. 2
Open Access | Times Cited: 35

Showing 1-25 of 35 citing articles:

PBMC transcriptomic signatures reflect Trypanosoma cruzi strain diversity and trained immunity in chronically infected macaques
Hans Desale, Weihong Tu, Kelly Goff, et al.
JCI Insight (2025)
Open Access | Times Cited: 1
State-of-the-Art in the Drug Discovery Pathway for Chagas Disease: A Framework for Drug Development and Target Validation
Juan Carlos Gabaldón-Figueira, Nieves Martínez-Peinado, Elisa Escabia, et al.
Research and Reports in Tropical Medicine (2023) Vol. Volume 14, pp. 1-19
Open Access | Times Cited: 18
The Trypanosoma cruzi Antigen and Epitope Atlas: antibody specificities in Chagas disease patients across the Americas
Alejandro D. Ricci, Leonel Bracco, Emir Salas‐Sarduy, et al.
Nature Communications (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 17
Enteric nervous system regeneration and functional cure of experimental digestive Chagas disease with trypanocidal chemotherapy
Archie A. Khan, Harry C. Langston, Louis Walsh, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 5
Coinfection by multiple Trypanosoma cruzi clones: a new perspective on host-parasite relationship with consequences for pathogenesis and management of Chagas disease
Yves Carlier, Eric Dumonteil, Claudia Herrera, et al.
Microbiology and Molecular Biology Reviews (2025)
Closed Access
Adipose Tissue in Chagas Disease: A Neglected Component of Pathogenesis
Vitória França dos Santos Pessoa, Mariana Hecht, Nadjar Nitz, et al.
Pathogens (2025) Vol. 14, Iss. 4, pp. 339-339
Open Access
Local association of Trypanosoma cruzi chronic infection foci and enteric neuropathic lesions at the tissue micro-domain scale
Archie A. Khan, Harry C. Langston, Fernanda Cristina Costa, et al.
PLoS Pathogens (2021) Vol. 17, Iss. 8, pp. e1009864-e1009864
Open Access | Times Cited: 28
Cardiomyocyte infection by Trypanosoma cruzi promotes innate immune response and glycolysis activation
Gabriela Venturini, Juliana Morais Alvim, Kallyandra Padilha, et al.
Frontiers in Cellular and Infection Microbiology (2023) Vol. 13
Open Access | Times Cited: 12
Vaccination with parasite-specific TcTASV proteins combined with recombinant baculovirus as a delivery platform protects against acute and chronic Trypanosoma cruzi infection
Yamil E. Masip, Lucas D. Caeiro, Maximiliano Cosenza, et al.
Frontiers in Cellular and Infection Microbiology (2024) Vol. 14
Open Access | Times Cited: 4
Anti-inflammatory and immunomodulatory effects of mesenchymal stem cell therapy on parasitic drug resistance
Soheil Sadr, Pouria Ahmadi Simab, Mahta Niazi, et al.
Expert Review of Anti-infective Therapy (2024) Vol. 22, Iss. 6, pp. 435-451
Closed Access | Times Cited: 4
In Vivo Imaging of Cardiac Attachment of TcI and TcII Variants of Trypanosoma cruzi in A Zebrafish Model
Victoria E. Rodriguez-Castellanos, Cristhian David Perdomo-Gómez, Juan Carlos Santos‐Barbosa, et al.
Pathogens (2025) Vol. 14, Iss. 1, pp. 25-25
Open Access
Arrhythmogenic Manifestations of Chagas Disease: Perspectives From the Bench to Bedside
Danilo Roman‐Campos, José Antônio Marin‐Neto, Artur Santos‐Miranda, et al.
Circulation Research (2024) Vol. 134, Iss. 10, pp. 1379-1397
Open Access | Times Cited: 3
Animal models for exploring Chagas disease pathogenesis and supporting drug discovery
Archie A. Khan, Martin C. Taylor, Amanda Fortes Francisco, et al.
Clinical Microbiology Reviews (2024) Vol. 37, Iss. 4
Closed Access | Times Cited: 3
Recent Advances in the Development of Adenovirus-Vectored Vaccines for Parasitic Infections
Cal Koger-Pease, Dilhan J. Perera, Momar Ndao
Pharmaceuticals (2023) Vol. 16, Iss. 3, pp. 334-334
Open Access | Times Cited: 7
CD39 expression by regulatory T cells participates in CD8+ T cell suppression during experimental Trypanosoma cruzi infection
Cintia L. Araujo Furlan, Santiago Boccardo, Constanza Rodríguez, et al.
PLoS Pathogens (2024) Vol. 20, Iss. 4, pp. e1012191-e1012191
Open Access | Times Cited: 2
Incomplete Recruitment of Protective T Cells Is Associated with Trypanosoma cruzi Persistence in the Mouse Colon
Alexander I. Ward, Michael D. Lewis, Martin C. Taylor, et al.
Infection and Immunity (2021) Vol. 90, Iss. 2
Open Access | Times Cited: 14
Hypoxia Effects on Trypanosoma cruzi Epimastigotes Proliferation, Differentiation, and Energy Metabolism
Francis M. S. Saraiva, Daniela Cosentino-Gomes, Job D. F. Inacio, et al.
Pathogens (2022) Vol. 11, Iss. 8, pp. 897-897
Open Access | Times Cited: 9
Comparing in vivo bioluminescence imaging and the Multi-Cruzi immunoassay platform to develop improved Chagas disease diagnostic procedures and biomarkers for monitoring parasitological cure
Amanda Fortes Francisco, Ursula Saade, Shiromani Jayawardhana, et al.
PLoS neglected tropical diseases (2022) Vol. 16, Iss. 10, pp. e0010827-e0010827
Open Access | Times Cited: 9
Pathogenesis of protozoan infections
Abdul Mannan Baig, Xun Suo, Dongyou Liu
Elsevier eBooks (2024), pp. 2921-2940
Closed Access | Times Cited: 1
7-Aryl-7-deazapurine 3′-deoxyribonucleoside derivative as a novel lead for Chagas’ disease therapy: in vitro and in vivo pharmacology
Camila Cardoso-Santos, Ludmila Ferreira de Almeida Fiuza, Cristiane França da Silva, et al.
JAC-Antimicrobial Resistance (2021) Vol. 3, Iss. 4
Open Access | Times Cited: 10
Is a negative correlation between sTNFR1 and TNF in patients with chronic Chagas disease the key to clinical progression?
Diego José Lira Torres, Tiago Ribeiro de Arruda, Michelle da Silva Barros, et al.
Immunobiology (2021) Vol. 227, Iss. 1, pp. 152166-152166
Closed Access | Times Cited: 7
Sheltered in Stromal Tissue Cells, Trypanosoma cruzi Orchestrates Inflammatory Neovascularization via Activation of the Mast Cell Chymase Pathway
Lucas Vellasco, Erik Svensjö, Carlos A. Bulant, et al.
Pathogens (2022) Vol. 11, Iss. 2, pp. 187-187
Open Access | Times Cited: 3
Parasite-microbiota interactions: a pathway to innovative interventions for Chagas disease, leishmaniasis, and ascariasis
Juan David Ramírez, Sergio Castañeda, Jill E. Weatherhead, et al.
Future Microbiology (2024), pp. 1-13
Closed Access
Intermittent suppressive posaconazole therapy is ineffective at mitigating cardiac and digestive tract pathologies in an experimental model of chronic Chagas disease
Shiromani Jayawardhana, Francisco Olmo, Amanda Fortes Francisco, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access
Page 1 - Next Page

Scroll to top